Cost-effectiveness of domiciliary non-invasive ventilation in patients with chronic obstructive pulmonary disease.

James A Hall Alice Margaret TurnerJanine DretzkeDavid MooreSusan Jowett

Published in: Thorax (2021)

Domiciliary NIV is likely cost-effective for posthospitalised patients, with uncertainty around the cost-effectiveness of domiciliary NIV in stable patients with COPD on which further research should focus.

Keyphrases

chronic obstructive pulmonary disease
lung function
respiratory failure
cystic fibrosis
acute respiratory distress syndrome